Browsing by Author "Paşa S."
Now showing items 1-4 of 4
-
Assessment of patients with thrombotic thrombocytopenic purpura
Demir C.; Altintaş A.; Paşa S.; Ali Kaplan M.; Küçükzeybek Y.; Ayyildiz O. (2010)Thrombotic thrombocytopenic purpura (TTP) is a severe microvascular occlusive thrombotic microangiopathy characterized by systemic platelet aggregation, organ ischemia, profound thrombocytopenia, and fragmentation of ... -
Cranial involvement in a follicular lymphoma patient with systemic complete remission after Yttrium-90-ibritumomab-tiuxetan treatment: Scientific letter
Çil T.; Altintaş A.; Paşa S.; Kilinç I.; Işikdoğan A. (Turkiye Klinikleri, 2008)Non-Hodgkin's lymphoma is a heterogeneous group of lymphoproliferative disorders with varying patterns of behavior and treatment responses. Advances in understanding of tumor biology have made it possible to exploit novel ... -
Gastric ring cell carcinoma metastasis to the breast: Two case reports
Çil T.; Altintaş A.; Paşa S.; Işikdoğan A. (2009)Metastatic tumors of breast are rare and account only for approximately 2% of all malignant breast cancers. Breast metastasis of stomach's signet ring cell carcinoma (SRCC) is also a very rare condition. Herein, we report ... -
Retinoic acid syndrome after the first dose of all-trans retinoic acid
Altintaş A.; Paşa S.; Ağgil C.; Tural B.; Ayyildiz O. (2006)All-trans retinoic acid (ATRA) was firstly used as a differentiating agent in 1987 in Shanghai for the treatment of acute promyelocytic leukemia (APL). Retinoic Acid Syndrome (RAS) became an important complication of therapy ...
